Results 251 to 260 of about 2,437,403 (392)

Low dose tezosentan, an intravenous dual endothelin receptor antagonist, decreases type B-natruretic peptide levels in patients with acute decompensated heart failure [PDF]

open access: bronze, 2003
Guillermo Torre‐Amione   +13 more
openalex   +1 more source

Supplementary Figure S6 from Endothelin A Receptor/β-Arrestin Signaling to the Wnt Pathway Renders Ovarian Cancer Cells Resistant to Chemotherapy

open access: gold, 2023
Laura Rosanò   +9 more
openalex   +1 more source

The Use of Treprostinil for Bronchopulmonary Dysplasia Associated Pulmonary Hypertension

open access: yesPediatric Pulmonology, Volume 61, Issue 1, January 2026.
ABSTRACT Background Treprostinil for the treatment of bronchopulmonary dysplasia‐associated pulmonary hypertension (BPD‐PH) has previously been described in small cohort studies, often used later in the course after failure to improve on other therapies.
Stephanie M. Tsoi   +8 more
wiley   +1 more source

Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting. [PDF]

open access: yesFront Endocrinol (Lausanne), 2022
Speck D   +6 more
europepmc   +1 more source

Endothelin-A receptor-dependent and -independent signaling pathways in establishing mandibular identity

open access: green, 2004
L. Bruno Ruest   +4 more
openalex   +1 more source

Global Resource Disparities Between Pulmonary Hypertension Centers: Results From the International Survey by the PVRI IDDI Access to Care Workstream

open access: yesPulmonary Circulation, Volume 16, Issue 1, January 2026.
ABSTRACT There is a limited understanding of how pulmonary hypertension (PH) patients are managed worldwide. The Pulmonary Vascular Research Institute (PVRI) Innovative Drug Discovery Initiative (IDDI) global survey attempted to obtain insights into access to PH care in diverse international regions to pave future action plans.
Sasha Z. Prisco   +9 more
wiley   +1 more source

Protective Effects of Bosentan via Endothelin Receptor Antagonism in Experimental Ischemia-Reperfusion Injury in the Lower Limb of Rats. [PDF]

open access: yesDrug Des Devel Ther
Demirtaş H   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy